Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Cited by (874)

Items 601–700 of 874

1. Tumor-infiltrating regulatory T cell: A promising therapeutic target in tumor microenvironment
   Tianning Huang, Fan Li, Yiming Wang, Jian Gu, Ling Lü · 2024 · Chinese Medical Journal
2. Liver metastasis of colorectal cancer: Mechanism and clinical therapy (Review)
   Changjiang Yang, Long Zhao, Caihong Wang, Yingjiang Ye, Zhanlong Shen · 2025 · Oncology Reports
3. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment
   Aitoshi Hoshimoto, Atsushi Tatsuguchi, Ryohei Hamakubo, Takayoshi Nishimoto, Jun Omori, Naohiko Akimoto, Shu Tanaka, Shunji Fujimori, Tsutomu Hatori, Akira Shimizu et al. · 2023 · World Journal of Gastroenterology
4. Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma
   Yanli Luo, Sheng Zhang, Huilin Xie, QiaoFeng Su, Shuang He, Zhen Lei · 2023 · Cellular and Molecular Biology
5. Chemical immunology: Recent advances in tool development and applications
   Yujie Shi, Eleanor E. Bashian, Yingqin Hou, Peng Wu · 2024 · Cell chemical biology
6. Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR–T) cell immunotherapy
   Zhengyi Wang, LIANG ZHOU, XIAOYING WU · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
7. Characterisation of colorectal cancer by hierarchical clustering analyses for five stroma‐related markers
   Sunao Ito, Akira Koshino, Chengbo Wang, Takahiro Otani, Masayuki Komura, Akane Ueki, Shunsuke Kato, Hiroki Takahashi, Masahide Ebi, Naotaka Ogasawara et al. · 2024 · The Journal of Pathology Clinical Research
8. The prognostic impact of tumor mutations and tumor-infiltrating lymphocytes in patients with localized pMMR colorectal cancer – A systematic review and meta-analysis
   Amalie Thomsen Nielsen, Ida Kolukisa Saqi, Tobias Freyberg Justesen, Michael Tvilling Madsen, Ismail Gögenür, Adile Orhan · 2025 · Critical Reviews in Oncology/Hematology
9. Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review)
   Xiaohong Lyu, Jiashu Han, Lin Chen, Yidong Zhou, Weibin Wang · 2025 · International Journal of Oncology
10. Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancer
    Zhao Gao, Xiaoyan Wang, Tao Song, Shikai Wu, Xuan Shun Jin · 2025 · Scientific Reports
11. Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer
    Bing Yan, Jianmei Xiong, Qianwen Ye, Tianhui Xue, Jia Xiang, Mingyue Xu, Fang Li, Wei Xiong Wen · 2022 · BMC Gastroenterology
12. Identification of subtypes of clear cell renal cell carcinoma and construction of a prognostic model based on fatty acid metabolism genes
    Shiwen Nie, Youlong Huili, Anliang Yao, Jian Liu, Yong Wang, Lei Wang, Liguo Zhang, Shaosan Kang, Fenghong Cao · 2022 · Frontiers in Genetics
13. Identification of a prognostic index system and tumor immune infiltration characterization for lung adenocarcinoma based on mRNA molecular of pyroptosis
    Huawei Li, Xiaoyan Chang, Haiyan Wang, Bo Peng, Jun Wang, Pengfei Zhang, Linyou Zhang · 2022 · Frontiers in Medicine
14. A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer
    Weiyu Ge, Daiyuan Shentu, Yongchao Wang, Yanling Wang, Shengbai Xue, Ming Yue, Tiebo Mao, Xiaofei Zhang, Haiyan Xu, Shumin Li et al. · 2022 · Frontiers in Cell and Developmental Biology
15. A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma
    Qixuan Li, Tianyi Wang, Jiaqi Zhu, Anping Zhang, Anqi Wu, You Lang Zhou, Jiahai Shi · 2023 · Annals of Translational Medicine
16. Establishment of a prognostic model related to tregs and natural killer cells infiltration in bladder cancer
    Yanjie Yang, Xiaoqing Xu, Yichao Zhang, Peng-Cheng Hu, Wu-Xia Yang · 2023 · World Journal of Clinical Cases
17. Expanded Alternatives of CRISPR–Cas9 Applications in Immunotherapy of Colorectal Cancer
    Ruben Dario Arroyo-Olarte, Aranza Mejía-Muñoz, Sonia León‐Cabrera · 2023 · Molecular Diagnosis & Therapy
18. Decrease in regulatory T-cell function in chronic hepatitis C patients receiving pegylated-interferon plus ribavirin
    Kuo‐Chih Tseng, Yun‐Che Ho, Chi-Wei Tseng, Ling-Huei Tseng, Yu‐Hsi Hsieh, Ting‐Tsung Chang, Shu‐Fen Wu · 2017 · International Journal of Infectious Diseases
19. Role of Immune Microenvironmental Factors for Improving the IPI-related Risk Stratification of Aggressive B Cell Lymphoma.
    Yi Gong, Rui Chen, Xi Zhang, Zhongmin Zou, Xing Hua Chen · 2017 · PubMed
20. The Multifaceted Effects of Gut Microbiota on the Immune System of the Intestinal Mucosa
    Takehiro Hirano, Hiroshi Nakase · 2021 · Immuno
21. Correlations between Circulating and Tumor-Infiltrating CD4+ T Cell Subsets with Immune Checkpoints in Colorectal Cancer
    Mohammad A. Al-Mterin, Khaled Murshed, Eyad Elkord · 2022 · Vaccines
22. Endothelial Cells Activated by Extracellular Histones Promote Foxp3+ Suppressive Treg Cells In Vitro
    Marine Arnaud, Jordane Demonchy, Eden Arrii, Marta Luperto, Julien Lion, Sofiane Fodil, Stéphanie Pons, Nuala Mooney, Lara Zafrani · 2022 · International Journal of Molecular Sciences
23. Prognostic impact of CD4+ and CD8+ tumor-infiltrating lymphocytes in patients with colorectal cancer
    Yong Tao, Ya Xie · 2023 · Acta chirurgica Belgica
24. Clinical significance of the expression of FOXP3 and TIGIT in Merkel cell carcinoma
    Takeshi Iwasaki, Kazuhiko Hayashi, Michiko Matsushita, Daisuke Nonaka, Takamasa MATSUMOTO, Midori Taniguchi, Satoshi Kuwamoto, Yoshihisa Umekita, Yoshinao Oda · 2023 · Scientific Reports
25. Follicular lymphoma microenvironment: insights provided by single-cell analysis
    Yoshiaki Abe · 2023 · Journal of the Japan Society of the Reticuloendothelial System
26. ＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.
    Vitaly Kochin, Hiroyoshi Nishikawa · 2019 · Europe PMC (PubMed Central)
27. Role of Crosstalk Between Gut Microbiota and Immune Cells in Colorectal Cancer: A Narrative Review
    Mengke Ye, Guangxun Yuan, Yue Jin, Xun Zeng · 2025 · Infectious Microbes & Diseases
28. Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3
    Qian Wei, Håvard Foyn, Johannes Landskron, Shixiong Wang, Inga Hansine Rye, Sigrid Strand Skånland, Hege Elisabeth Giercksky Russnes, Jo Klaveness, Ahmad Rafi, Kjetil Taskén · 2025 · iScience
29. Purine metabolism: a pan-cancer metabolic dysregulation across circulation and tissues
    Mengjie Yu, Cheng Liu, Minmin Cao, Dou Yang, Tongshan Wang, Jing Xu, Danxia Zhu, Guangji Wang, Jiye Aa, Wei Zhu · 2025 · Molecular Cancer
30. T-cell Subset Features and Distributions Evolve across the Colorectal Precancer–Cancer Spectrum
    Yasutoshi Takashima, Andressa Dias Costa, Naohiko Akimoto, Tomotaka Ugai, Phoenix D. Bell, Juha P. Väyrynen, Jason L. Hornick, Mari A. Mino-Kenudson, Yuxue Zhong, Satoko Ugai et al. · 2025 · Cancer Immunology Research
31. Understanding the Tumor Microenvironment and Therapy Resistance in Head and Neck Squamous Cell Carcinoma
    Abhinav Bagchi, Ratna B. Ray · 2025 · Cells
32. Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy
    Yue Ma, Xin Xu, Huaitao Wang, Yang Liu, Haiyan Piao · 2023 · Frontiers in Immunology
33. Neoadjuvante Immuntherapie bei Kopf-Hals- Plattenepithelkarzinomen
    Cornelius H. L. Kürten, Robert Louis Ferris · 2024 · Laryngo-Rhino-Otologie
34. A positive FOXP3/lncRNA SNHG1 feedback axis ameliorates cardiomyocytes hypertrophy by negatively regulating Parkin-mediated mitophagy
    Jingyi Zhang, Xuemei Luo, Xian Yang, Baoyan Wang, Lufeng Zheng, Simin Yan · 2024 · International Immunopharmacology
35. Causal relationship between immune cell signatures and colorectal cancer: a bi-directional, two-sample mendelian randomization study
    Ruizhi Liu, Liansha Tang, Yunjia Liu, Handan Hu, Jiyan Liu · 2025 · BMC Cancer
36. HES1 in cancer: a key player in tumorigenesis and its prognostic significance
    Venkataraman Magesh, Ramya Sekar, Abdullah M. Alzahrani, Rajkapoor Balasubramanian, Salaheldin Abdelraouf Abdelsalam, Peramaiyan Rajendran · 2025 · Molecular Genetics and Genomics
37. Analysis of the immune microenvironment in colorectal cancer with different KRAS gene subtypes
    Jing Huang, Qian Gong, Qingshu Li, Ming Xiao, Ming Li, Shuxian Zhang, Yalan Wang, Yi Tang · 2025 · BMC Cancer
38. Impact of oral anaerobic bacteria on the tumor immune microenvironment and prognosis of oral cancer
    Kana Kashima, Takuro Saito, Hitomi Kajikawa, Atsunari Kawashima, Azumi Ueyama, Narikazu Uzawa, Hisashi Wada · 2025 · Journal of Translational Medicine
39. The efficient circulating immunoscore predicts prognosis of patients with advanced gastrointestinal cancer
    Yamei Zhao, Yan Jun Tang, Hanlin Qin, Kehai Feng, Chang-Lu Hu · 2022 · World Journal of Surgical Oncology
40. The Effect of Lung Resection for NSCLC on Circulating Immune Cells: A Pilot Study
    Joseph D. Phillips, Kayla A. Fay, Alan J. Bergeron, Peisheng Zhang, Daniel W. Mielcarz, Andrew M. Calkins, Tyler G. Searles, Brock C. Christensen, David J. Finley, Mary Jo Turk et al. · 2023 · Current Oncology
41. Case Report: Genetic and immune microenvironmental characteristics of a rectal cancer patient with MSS/PD-L1-negative recurrent hepatopulmonary metastasis who achieved complete remission after treatment with PD-1 inhibitor
    Yang Song, Juan Long, Xiaona Su, Zhuo Chen, Yue He, Weikang Shao, Bin Wang, Chuan Chen · 2023 · Frontiers in Immunology
42. Beneficial effects of Hawthorn extract on metabolic hypertensive rats by regulating Treg/Th17 immune balance
    Bing-Bing Cheng, Zeqi Hu, Bo Li, Xiang Zheng, Lin-Zi Li, Yingjie Dong, Xinglishang He, Guiyuan Lv, Suhong Chen, Ning-Hua Jiang · 2023 · Journal of Functional Foods
43. Mathematical model for IL-2-based cancer immunotherapy
    Megan Dixon, Tuan Anh Phan, J. C. Dallon, Jianjun Paul Tian · 2024 · Mathematical Biosciences
44. CD4+ Regulatory T Cells in Human Cancer: Subsets, Origin, and Molecular Regulation
    Julian Swatler, Marco De Luca, Ivano Rotella, Veronica Lise, Emilia Maria Cristina Mazza, Enrico Lugli · 2024 · Cancer Immunology Research
45. The canonical Hippo pathway components modulate the differentiation of lamina propria regulatory T cells and T helper 17-like regulatory T cells in mouse colitis
    Liuqing Ge, Min Jian Xu, Meifang Huang, Shaoping Liu, Zhidai Zhou, Ziqin Xia, Shouquan Dong, Qiu Zhao, Ruiping Zhu, Feng Zhou · 2024 · International Immunology
46. Noncoding RNAs as novel immunotherapeutic tools against cancer
    Maninder Kaur, Bhavneet Kaur, Monidipa Konar, Sadhna Sharma · 2022 · Advances in protein chemistry and structural biology
47. Context-Dependent Effects Explain Divergent Prognostic Roles of Tregs in Cancer
    Elise Amblard, Vassili Soumelis · 2022 · Cancers
48. Prospect of ULK1 modulators in targeting regulatory T cells
    Young Jun Park, Jaebong Jang · 2022 · Bioorganic Chemistry
49. Prevalence of FoxP3+ Cells Does Not Correlate With Ki67 Expression in Canine Diffuse Large B-cell Lymphoma
    Clare Muir, Simon Lawrence Priestnall, Angie Hibbert, C. Brown, Oliver A. Garden, Tim J. Scase · 2017 · Journal of Comparative Pathology
50. Microbiome and Diseases: Colorectal Cancer
    Amina Iftekhar, Andreas Sperlich, Klaus‐Peter Janssen, Michael J. Sigal · 2018 · Springer eBooks
51. Ulcerative colitis and colorectal cancer: Pathogenic insights and precision strategies for prevention and treatment
    Martina Catalano, Enrico Mini, Stefania Nobili, Ismaela Anna Vascotto, Delia Ravizza, Andrea Amorosi, Francesco Tonelli, Franco Roviello, Giandomenico Roviello, Gabriella Nesi · 2025 · World Journal of Gastrointestinal Oncology
52. Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients
    Siqi Cai, Miaoqing Zhao, Guanqun Yang, Chaozhuo Li, Mengyu Hu, Liying Yang, Ligang Xing, Xiaorong Sun · 2024 · International Immunopharmacology
53. Bacterial information in serum extracellular vesicles reflects the inflammation of adherent perinephric fat
    Toshihiro Uemura, Atsunari Kawashima, Kentaro Jingushi, Daisuke Motooka, Takuro Saito, Nesrine Sassi, Yuki Horibe, Akinaru Yamamoto, Yutong Liu, Masaru Tani et al. · 2024 · Cancer Science
54. Impact of HTLV-1 infection on clinicopathological characteristics and tumour immune microenvironment in colorectal cancer
    Rin Yamada, Kota Arima, Hiromu Yano, Yukio Fujiwara, Kohei Yamashita, Kosuke Kanemitsu, Norihisa Hanada, Jun‐ichirou Yasunaga, Masaaki Iwatsuki, Yoshiki Mikami et al. · 2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
55. The Role of Tregs in the Tumor Microenvironment
    Yohei Sato · 2025 · Biomedicines
56. Acquired resistance of cancer therapies: Mechanisms and perspectives
    Manli Wang, Xiaoqian Zhai, Jiayao Li, Jiale Chen, Xiyue Gai, Xunxi Liu, Yu Liu, Qinghua Zhou, Chong Chen · 2026 · Chinese Medical Journal
57. Targeting regulatory T cells for cancer immunotherapy: promises and pitfalls
    Oriol Mirallas, Giulia Pretelli, M. Balsa Pena, Pablo Jiménez-Labaig, A. Hernando-Calvo, H Nathan Tan, Paul Nevins Selvadurai, Paulino Tallón de Lara, María Vieito, Juan Martín-Liberal et al. · 2026 · Annals of Oncology
58. Directing the Future Breakthroughs in Immunotherapy: The Importance of a Holistic Approach to the Tumour Microenvironment
    Hannah V. Newnes, Jesse D. Armitage, Katherine M. Audsley, Anthony Bosco, Jason C. Waithman · 2021 · Cancers
59. The Heightened Importance of EZH2 in Cancer Immunotherapy
    Xiaohu Lin, Wenkai Zhou, Chengzhong Lin, Wei Cao · 2023 · Cancer Screening and Prevention
60. Assessing TGF-β Prognostic Model Predictions for Chemotherapy Response and Oncogenic Role of FKBP1A in Liver Cancer
    Weimei Chen, Qinghe Que, Rongrong Zhong, Lin Zhou, Qiaolan Yi, Qingshui Wang · 2024 · Current Pharmaceutical Design
61. Forkhead Box Protein P3 in the Immune System
    Yohei Sato · 2025 · Allergies
62. Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer
    Kexun Zhou, Xuyu Gu, Huaicheng Tan, Ting Yu, Chunhua Liu, Zhenyu Ding, Jiyan Liu, Shi H · 2022 · Frontiers in Pharmacology
63. Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand
    Piyapharom Intarawichian, Sirada Sangpaibool, Piya Prajumwongs, Prakasit Sa-Ngiamwibool, Sakkarn Sangkhamanon, Waritta Kunprom, Malinee Thanee, Watcharin Loilome, Narong Khuntikeo, Attapol Titapun et al. · 2022 · Frontiers in Oncology
64. Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy
    Shahla’a Fadhil Sabir, Bassam Francis Matti, Wifaq M. Ali Al-Wattar · 2022 · Immunogenetics
65. Simplified and Optimized Immune Score for Colorectal Cancer Microenvironment
    HIROYUKI NAKANE, Tomoya Sudo, AKIHIRO KAWAHARA, Takatou Yomoda, Takahiro Shigaki, Kenji Fujiyoshi, Takafumi Ohchi, Kenichi Koushi, Takefumi Yoshida, TOSHIRO OGATA et al. · 2023 · Anticancer Research
66. Components of the tumor immune microenvironment based on m‐IHC correlate with prognosis and subtype of triple‐negative breast cancer
    Luyi Lin, Haiming Li, Xin Wei Wang, Zezhou Wang, Guan-Hua Su, Jiayin Zhou, Shiyun Sun, Xiaowen Ma, Yan Chen, Chao You et al. · 2023 · Cancer Medicine
67. Microbes in Tumoral In Situ Tissues and in Tumorigenesis
    Feng Xue, Lu Han, Sijia Ma, Lanbo Zhao, Lei Wang, Kailu Zhang, Panyue Yin, Lin Guo, Jing Wei, Qiling Li · 2020 · Frontiers in Cellular and Infection Microbiology
68. Dysbiosis of the duodenal microbiota as a diagnostic marker for pancreaticobiliary cancer
    Mitsuru Sugimoto, Kazumichi Abe, Tadayuki J. Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Ko Watanabe, Jun Nakamura et al. · 2021 · World Journal of Gastrointestinal Oncology
69. The Pioneer 9 electric field experiment: Part 1, near earth observations.
    Frederick L. Scarf, I.M. Green, G. M. Crook · 1971
70. Shengqiyichang decoction regulates antitumor immunity in colorectal cancer by downregulating lymphocyte antigen 6 family member G6D via the protein kinase B/p38 mitogen-activated protein kinase signaling pathway
    Run Xing Luo, Huai Liang Li, Yu Xiang Jia, Meng Gao, Zhao Yang Gao, Yi Ji, Shan Deng, Jie Ge Huo, Jian Zhang, Dong Zhang · 2024 · Heliyon
71. Mitochondrial Ribosomal Protein Family in Cancers: Mechanistic Insights and Therapeutic Implications
    Qian Chen, Yingli Zhang, Jin‐Jian Lu, Ting Li · 2025 · MedComm – Oncology
72. Tumor microenvironment heterogeneity and immunotherapy resistance: multidimensional modulation strategies for precision breakthroughs
    Yuhao Wei, Renwei Li, Yu Xiang, Huan Tong, Yu Zhang, Qianlong Kang, Juan Huang, Yige Bao, Xuelei Ma · 2026 · Journal of the National Cancer Center
73. From immunosuppression to active tolerance induction: an evolving paradigm of regulatory T cell-based therapy in organ transplantation
    Shao-Wei Li, Xin-Yu Fu, Hao-Ting Li, Hao Liu, Masayuki Fujino, Xiao‐Kang Li · 2026 · Immunity & Inflammation
74. Comprehensive analysis of necroptotic patterns and associated immune landscapes in individualized treatment of skin cutaneous melanoma
    Bo Yang, Pan Xie, Hongyu Huai, Junpeng Li · 2023 · Scientific Reports
75. Overexpression of regulatory T cells in patients with unexplained recurrent pregnancy loss: friend or foe?
    Pengcheng Liu, Jianbin Li, Yi-ping Huang, Min Zhang, Shu-jiao Yu, Rui Wu · 2024 · Frontiers in Medicine
76. Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma
    Hualan Hong, Xi Shi, Wenyong Ou, Pengju Ou · 2024 · Biomedical Reports
77. Capturing Hydrophilic Chemotherapeutics Agents Into siRNA‐Encapsulated Vesicle‐Like Nanoparticles for Convenient ICB‐Chemo Combination Therapy
    Yan Li, Bingqin Li, Chaoran Chen, Hengliang Hou, Miao Su, Fangzheng Li, Zekai Xiao, Xianzhu Yang · 2024 · Small
78. Qualitative Transcriptional Signature for Predicting the Pathological Response of Colorectal Cancer to FOLFIRI Therapy
    Jun He, Mengyao Wang, Dandan Wu, Hao Fu, Xiaopei Shen · 2024 · International Journal of Molecular Sciences
79. Association Between Oral Microbiota and Gastrointestinal/Extra-Gastrointestinal Diseases
    Do-Young Park, Young-Youn Kim, Chang Kee Kim, Inseong Hwang, Jeong-Hoo Lee, Jiyoung Hwang, Ju-Yeong Hwang · 2024 · The Korean Journal of Helicobacter and Upper Gastrointestinal Research
80. Multi-cellular phenotypic dynamics during the progression of an immunocompetent breast cancer model
    Louise Gsell, Spencer S. Watson, Iva Sutevski, Matteo Massara, Klara Soukup, Alper Eroğlu, Jeff Eron Mold, Antony Cougnoux, Johanna A. Joyce, Jean Hausser · 2025 · iScience
81. FOXP3 rs2280883 polymorphism confers susceptibility to colorectal cancer in a Chinese Han population
    Ying Yiing Lou, Minhui Fan, Renya Shuai, Yao Cheng · 2020 · Gene
82. Cuproptosis combines immune landscape providing prognostic biomarker in head and neck squamous carcinoma
    Tingting Shu, Xudong Wang · 2023 · Heliyon
83. Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer
    Dae Won Kim, Youngchul Kim, Bence P. Kovari, Maria Martinez, Ruoyu Miao, James B. Yu, Rutika Jitesh Mehta, Jonathan Strosberg, Iman Imanirad, Richard D. Kim · 2024 · Cancers
84. Pyroptosis-related gene signature for predicting gastric cancer prognosis
    Salem Saeed Saad Khamis, Jianhua Lu, Yongdong Yi, Shangrui Rao, Weijian Sun · 2024 · Frontiers in Oncology
85. A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancer
    Luis Munoz‐Erazo, Saem Mul Park, Shelly Lin, Chun‐Jen J. Chen, Lisa Y. Y. Zhou, Janet L Rhodes, Taesung Jeon, Sonya Fenton, John L McCall, Roslyn A. Kemp et al. · 2025 · Frontiers in Immunology
86. Determination of a CD4+CD25+ Foxp3+T cells subset in Egyptian Colorectal Cancer Patients
    Nadia Elsheshtawy, Marwa Saad, Yasser Elghamrini, Kholood Ziad · 2021 · Egyptian journal of Immunology
87. Transcriptional heterogeneity in cancer-associated regulatory T cells is predictive of survival
    Nicholas C. Borcherding, Kawther Khalid Ahmed, Andrew P. Voigt, Ajaykumar Vishwakarma, Ryan H. Kolb, Paige Kluz, Gaurav Pandey, Katherine Nicole Gibson-Corley, Julia Klesney‐Tait, Yuwen Zhu et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
88. Bystander CD4 + T cells infiltrate human tumors and are phenotypically distinct
    Yannick Simoni, Shamin Li, Summer Zhuang, Antja Heit, Si‐Lin Koo, I‐Ting Chow, William W. Kwok, Iain Beehuat Tan, Daniel S.W. Tan, Evan William Newell · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
89. Development of therapeutic cancer vaccines based on cancer immunity cycle
    Jing Zhang, Yiyuan Zheng, Lili Xu, Jing Gao, Zhuoyu Ou, Mingzhao Zhu, Wenjun Wang · 2025 · Frontiers of Medicine
90. Clinical Relevance of FOXP3, PD-L1, PD-1, and miR-155 Gene Expression and Genetic Variants in HPV-Negative Oral Carcinomas
    Nemanja Ivkovic, Debora Misic, Ružica Kozomara, Saša Jović, Ahmad Salah Sami, Gordana S. Velikic, Srboljub Stošić, Gordana Šupić · 2025 · International Journal of Molecular Sciences
91. A laminin α4–CD8 + T cell axis shapes the prognostic impact of macrophages and regulatory T cells in early-stage colorectal cancer
    Elena Nonnast, María Jesús Fernández‐Aceñero, Tirso Pons, María Pilar Díaz Suárez, Carlos Óscar S. Sorzano, Emilia Mira, Santos Mañes · 2025 · OncoImmunology
92. Expression of Bacillus in colorectal tissues is associated with improved cetuximab therapy for patients with metastatic colorectal cancer
    Hung‐Chih Hsu, Hsin-Yu Chung, Jeng‐Fu You, Yun-Shien Lee, Jeng‐Shou Chang, Hsin‐Han Hou, Chuang‐Wei Wang · 2025 · Translational Oncology
93. Immune Landscape and Role of Immunotherapy in Treatment of HPV-Associated Head and Neck Squamous Cell Carcinoma (HNSCC)
    Hannah R. Turbeville, Tiffany Toni, Clint Tanner Allen · 2022 · Current Otorhinolaryngology Reports
94. PD‑1/PD‑L1 blockade, a novel strategy for targeting metastatic colorectal cancer: A systematic review and meta‑analysis of randomized trials
    Maria Saveria Rotundo, Vincenzo Bagnardi, Miryam Rotundo, Mario Comandè, Maria Giulia Zampino · 2022 · Oncology Letters
95. Metabolic reprogramming drives homeostasis and specialization of regulatory T cells in cancer
    Le Li, Zezhong Xiong, Zhiquan Hu, Xing Zeng, Zhihua Wang · 2022 · Oncology and Translational Medicine
96. Prognostic significance of tumor microenvironment assessed by machine learning algorithm in surgically resected non‐small cell lung cancer
    Yukihiro Terada, Mitsuhiro Isaka, Akira Ono, Takuya Kawata, Masakuni Serizawa, Keita P. Mori, Koji Muramatsu, Kiyoshi Tone, Hirotsugu Kenmotsu, Keiichi Ohshima et al. · 2023 · Cancer Reports
97. Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinoma
    Anne-Laure Grindel, Nathalie Fretellier, Miguel Soares, Nabiha Bouzakher, Vincent Millot Maysounabe, Robin Santus, Olivia Bawa, Mélody Wintrebert, Clémence Couquelet, Philippe Robert et al. · 2024 · Frontiers in Immunology
98. Establishment of immune suppression by cancer cells in the tumor microenvironment
    Hiroyoshi Nishikawa · 2024 · Proceedings of the Japan Academy Series B
99. Insight into the significance of Foxp3 + tumor-infiltrating lymphocytes in squamous cell lung cancer
    Kazu Shiomi, Masaaki Ichinoe, Ai Ushiwata, Koji Eshima, Ryo Nagashio, Shoko Hayashi, Dai Sonoda, Yasuto Kondo, Raito Maruyama, Masashi Mikubo et al. · 2024 · Clinical & Translational Oncology
100. Immunosuppressive regulatory cells in cancer immunotherapy: restrain or modulate?
     Yan Wu, Dongfeng Chen, Yang Gao, Qinggang Xu, Yang Zhou, Zhong Ni, Manli Na · 2024 · Human Cell